跳至主要内容
临床试验/ISRCTN47102251
ISRCTN47102251已完成未知

Antibiotic-lock technique with Taurolidine for prevention of central venous catheter infection in neutropenic patients: a randomized, double-blind, placebo-controlled study

The Carlos III Health Institute (Instituto de Salud Carlos III)0 个研究点目标入组 150 人开始时间: 2015年10月21日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adult patients aged > 18 years
  • 2. Hospitalized with leukemia, lymphoma or stem cell transplantation
  • 3. Carry a central venous catheter
  • 4. Likely to develop neutropenia (<500 neutrophils per ul) lasting more than one week

排除标准

  • 1. Patients with a (not flexible) semi-rigid central venous catheter
  • 2. Patients who have been found to have a positive culture of the hubs or the insertion site of the catheter, previously to randomization
  • 3. Patients in whom the central venous catheter is used for parenteral nutrition or medication that needs continuous infusion
  • 4. Patients receiving systemic antibiotic treatment = 48 hours
  • 5. Patients who have an active infection at the baseline statement

研究者

发起方
The Carlos III Health Institute (Instituto de Salud Carlos III)

相似试验

Antibiotic-lock technique with Taurolidine for... | 临床试验